Home | Welcome to Contract Pharma   
Last Updated Friday, July 25 2014
Print

Breaking News

February 12, 2013
Aims to discover, commercialize small-molecule therapies  Read More »
February 12, 2013
Lemke brings more than 20 years of experience  Read More »
February 12, 2013
Unaudited revenues up 44% in the quarter  Read More »
February 12, 2013
Applications range from drug delivery to physiological sensing  Read More »
February 12, 2013
BMS to market several OTC medicines in Latin America  Read More »
Gil Roth
February 11, 2013
Chai to take over tubulin compound  Read More »
Gil Roth
February 11, 2013
Rehse to lead Structural Biology  Read More »
February 11, 2013
Will manufacture and supply DEFINITY, Cardiolite and Neurolite  Read More »
February 11, 2013
Expands liquid categories and Rx medicines, broadens market access  Read More »
February 11, 2013
To provide solutions aimed at overcoming development challenges   Read More »
February 8, 2013
To invest $7.5 million in German facility  Read More »
February 8, 2013
Expands preclinical research services  Read More »
February 8, 2013
Brussels, Singapore sites now offer microbiology capabilities   Read More »
February 8, 2013
To evaluate merger, sale, or other transaction  Read More »
February 8, 2013
Will share global rights to marketed products  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On